01
A behavioral signal, by design
Our numberless dial keeps patients checking in and creates a behavioral signal competitors do not collect.
Seed round open · Paying customers live in Brazil & the NetherlandsPredict.
Predict.
Prevent.
Perform.
We are building the predictive infrastructure for the $1.5 trillion obesity care category — and we own the behavioral prediction space no one else owns.
Ew2health predicts who will stay and succeed — already deployed, revenue-generating, and validated in 30+ pilots.
Now
Paying customers
Live in Brazil & the Netherlands
Now
Seed round
€1.5M, open
Ahead
Expansion
US, UK, LatAm
The problem
A $1.5 trillion crisis with a leaky bucket at its center.
Obesity care loses patients, revenue, and outcomes through poor retention.
2B
people affected globally
$1.5T
annual financial burden worldwide
€10B
looming Netherlands healthcare bill
65%
patient dropout rate in obesity programs
Where we sit
The prediction layer any program runs on.
Manufacturers make the drug. Programs deliver care. Ew2health predicts who will stay and succeed, so teams can intervene earlier.
The medication
Manufacturers make the GLP-1 drugs.
The programs that deliver it
Clinics, telehealth and apps deliver care.
The prediction layer
Predicts who will stay and succeed — the intelligence all programs run on.
The competitor landscape
We predict behavior.
Others monitor biological or behavioral signals. Sinque occupies the open quadrant: predicting behavior before patients disengage.
PREDICT — forecast outcomes
Biometric signal
Behavioral signal →
Biometric signal
Predict biology — for pharma R&D
Dandelion
(data → pharma R&D)
+ RWE / precision-medicine players
Predict behavior — who will succeed
sinque
forecasts who stays & succeeds
Clinician RPM — biometric monitoring
Rimidi · CoachCare · HealthSnap · Vitalera
fed by CGMs · smart scales · vitals
Consumer apps & coaching — behavioral
Noom · Embla · WeightWatchers · MyFitnessPal · Second Nature · Oviva · Yazen
track the person — but don't forecast
Behavioral signal
MONITOR — track & alert
The defensible moat
Four layers of compounding defensibility.
Four connected advantages make the prediction layer hard to replicate.
02
Patented prediction
US Patent 11,633,160 protects our method of forecasting weight trajectory from behavioral signals.
03
Decision & workflow lock-in
Sinque turns forecasts into daily priorities: who needs attention and when. That embeds it in clinical workflow.
04
A compounding flywheel
More patients create more data, sharper predictions, better outcomes, and more clinic adoption.
Strategic validation
Research shaped with serious institutions.
Research, clinical collaboration, and live deployment support the Sinque platform.
DATA ANALYTICS
Mayo Clinic Platform_Accelerate
First Netherlands-based startup selected. Building predictive models against tens of thousands of GLP-1 treatment records.
CLINICAL RESEARCH
Hospital Israelita Albert Einstein
Earlier scientific pilot at one of Latin America’s most respected medical institutions; the relationship continues.
ONGOING RESEARCH
LUMC and NeLL
Ongoing grant-backed research into how predictive information is best presented to different users.
>2×
better outcomes through adherence and treatment success
25%
greater efficiency through triage and remote monitoring
50%
higher cash generation through retention and efficiency
REAL-WORLD DEPLOYMENT
Evidence from programs and paying clinics
Petrobras’ Motiva and MotivAÇÃO were workplace nutrition pilots, not GLP-1 programs; they improved retention and outcomes versus standard care. Paying clinics in Brazil and the Netherlands now use Sinque.
ECOSYSTEM PARTNERSHIPS
Roche and Garmin initiatives extend our view from behavior into metabolic signals.
See the biomarker initiatives on the Platform page →The expansion path
From serving clinics today to a global infrastructure layer tomorrow.
Three customer horizons, built on what we deliver today.
Now · 2026–2027
Medical weight-loss clinics and (corporate) programs
Paying clinics and programs generate recurring revenue, clinical data, and operating proof.
NL · BR
Next · 2027–2029
Telemedicine and virtual clinic chains
License behavioral intelligence across virtual networks in the US, UK, and Latin America.
US · UK · LATAM
Strategic · 2029+
Pharma, medtech and wearables
Become predictive infrastructure for pharma, medtech, wearables, and continuous diagnostics.
GLOBAL
The team
Founder-led. Multidisciplinary by design.
A Brazilian physician, a Dutch applied physicist, and an American operator combine clinical, technical, and international operating experience.
Visit the about page →Investor access
We are raising a seed round to scale in Brazil and The Netherlands.
Request the round terms, use of funds, traction, and financial forecast. Access is sent immediately and remains valid for 30 days.